Clinical Trials
-
ArQule announces tivantinib meets primary endpoint
ArQule announces tivantinib meets primary endpoint, significantly extending time to progression in Phase 2 trial in second-line hepatocellular carcinoma.
Clinical Trials | 13 March 2012
-
Xceleron announces move to purpose-built laboratories
Xceleron announced that existing investors Albion Ventures and Solon Ventures have invested US$2.4 million to locate all of the company’s business in its custom-built facility in Germantown, MD.
Clinical Trials | 09 March 2012
-
US FDA clears investigational new drug application, phase 2B trial for Immuron’s NASH/Fatty liver therapeutic
Immuron announced that the United States Food and Drug Administration (US FDA) had cleared an Investigational New Drug (IND) submission to commence a Phase 2b clinical trial of its bovine colostrum-derived therapeutic (IMM-124E) for the treatment of Non-Alcoholic Steatohepatitis (NASH) and Fatty Liver.
Clinical Trials | 06 March 2012
-
PACT selects Greenphire as an Enterprise Award finalist
Greenphire, a provider of payment technologies for the clinical trials industry, announced that it has been chosen as one of three finalists for the Philadelphia Alliance for Capital and Technologies (PACT) Enterprise Award in the technology startup division.
Clinical Trials | 22 February 2012
-
BiondVax’s universal flu vaccine improves existing flu vaccines in elderly
BiondVax Pharmaceuticals announced positive results from its second Phase II clinical trial (BVX-005) of the Universal Influenza Vaccine (Multimeric-001) developed by Biondvax for improving existing flu vaccines in elderly.
Clinical Trials | 20 February 2012
-
Telormedix secures further funding
Telormedix announced that it has raised 7.5 million CHF (US$8.1 million) from existing investors Aravis Venture and Proquest Investments.
Clinical Trials | 17 February 2012
-
Viralytics appoints non-executive director
Dr Leonard Post has been appointed as a non-executive director of Viralytics.
Clinical Trials | 14 February 2012
-
Life Technologies appoints president of medical sciences
Life Technologies announced that Ronnie Andrews, former CEO of Clarient and Segment Leader, GE Molecular Diagnostics, has joined the company as president, medical sciences.
Clinical Trials | 10 February 2012
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
Clinical Trials | 09 February 2012
-
Agilent Technologies’s Thought Leader Award supports Chris Evelo’s work at Maastricht University
Agilent Technologies the Agilent Technologies Foundation announced that Dr Chris Evelo and the department of bioinformatics at Maastricht University are the recipients of an Agilent Thought Leader Award supporting development of software to integrate different types of biological data. The goal of this award is to help accelerate breakthroughs in disease research by facilitating integrative systems biology approaches.
Clinical Trials | 06 February 2012
